Ivan Hyep insider trades

Open-market stock purchases and sales by Ivan Hyep, Chief Financial Officer at Bicara Therapeutics Inc, from SEC Form 4 filings since Oct 6, 2025.

Recent trades

DateStockTradeValue
May 21, 2026BCAX Bicara Therapeutics IncSold$188K
May 21, 2026BCAX Bicara Therapeutics IncBought (not open market)—
Apr 21, 2026BCAX Bicara Therapeutics IncSold$212K
Apr 21, 2026BCAX Bicara Therapeutics IncBought (not open market)—
Mar 23, 2026BCAX Bicara Therapeutics IncSold$170K
Mar 23, 2026BCAX Bicara Therapeutics IncBought (not open market)—
Mar 4, 2026BCAX Bicara Therapeutics IncSold$54.1K
Mar 4, 2026BCAX Bicara Therapeutics IncBought (not open market)—
Mar 3, 2026BCAX Bicara Therapeutics IncSold$247K
Mar 3, 2026BCAX Bicara Therapeutics IncBought (not open market)—
Mar 3, 2026BCAX Bicara Therapeutics IncBought (not open market)—
Feb 2, 2026BCAX Bicara Therapeutics IncBought (not open market)—
Jan 22, 2026BCAX Bicara Therapeutics IncSold$34.2K
Jan 22, 2026BCAX Bicara Therapeutics IncBought (not open market)—
Dec 22, 2025BCAX Bicara Therapeutics IncSold$168K
Dec 22, 2025BCAX Bicara Therapeutics IncBought (not open market)—
Nov 24, 2025BCAX Bicara Therapeutics IncSold$330K
Nov 24, 2025BCAX Bicara Therapeutics IncBought (not open market)—
Nov 21, 2025BCAX Bicara Therapeutics IncSold$11K
Nov 21, 2025BCAX Bicara Therapeutics IncBought (not open market)—
Oct 9, 2025BCAX Bicara Therapeutics IncSold$117K
Oct 9, 2025BCAX Bicara Therapeutics IncBought (not open market)—
Oct 8, 2025BCAX Bicara Therapeutics IncSold$102K
Oct 8, 2025BCAX Bicara Therapeutics IncBought (not open market)—
Oct 7, 2025BCAX Bicara Therapeutics IncSold$332K

Companies traded

  • BCAX Bicara Therapeutics Inc: 13 sales, last May 21, 2026

Get free alerts when Ivan Hyep files a new trade →